Microsystems is the leading provider of innovative document technology solutions and cutting-edge software worldwide. Its products optimize all stages of the document production life cycle, improving content quality and formatting, identifying errors and inconsistencies, mitigating risk and enhancing document production efficiency for the life science and other industries. Microsystems supports more than 650 document-intensive organizations across the globe, helping them satisfy the complex demands of clients and regulators.
Over the past two years, ShareVault has become a leading virtual data room provider in the life sciences industry. The company’s worldwide customers (in 48 countries) range from two-person virtual biotechs to large pharma and also include medical device and diagnostics manufacturers, small to large CROs and CMOs, healthcare systems, and life science-specific venture capital firms.
Within the biopharma arena, ShareVault is commonly used both for out-licensing and in-licensing as well as for M&A, and for sharing sensitive documents with internal regulatory affairs departments, CROs, CMOs and external regulatory advisors. ShareVault has also been adopted by large pharma for some extremely sensitive applications such as clinical trial transparency.
ShareVault is frequently recognized for its data room’s security, ease-of-use, speed and reliability, industry-leading and life science-specific features, customer support, and cost-effectiveness. For these reasons along with its very popular educational webinars and white papers, BIO and 36 other industry associations (including BIOTECanada and BIA) have chosen ShareVault as the official virtual data room provider for their member benefits programs.
Synchrogenix provides regulatory strategy, science, and services to pharmaceutical, device diagnostics, and tobacco companies worldwide. From global submission strategy and regulatory operations leadership to regulatory and medical writing, to transparency and disclosure compliance, we propel products from model to patient access.Through technology-enabled solutions, we optimize our contributions from early phase development through lifecycle management. Synchrogenix proudly leads the transformation of research and development through our end-to-end regulatory expertise and technology-enabled solutions.